Finland· FI-REL-REL43071
Translarna
A ataluren product containing ataluren, registered in Finland by PTC Therapeutics International Limited. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ataluren is registered in 6 of 19 countries.
Countries holding a registration under ATC M09AX03 (ataluren), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Ataluren · ATC M09AX03
6 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Ireland
- Polandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Ataluren
- Manufacturer
- PTC Therapeutics International Limited
- Country
- Finland (FI)
- ATC code
- M09AX03
- ATC class
- Ataluren
- Defined daily dose
- 2.8 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ataluren in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTRANSLARNA 1000 MG GRANULADO PARA SUSPENSION ORALPtc Therapeutics International Limited
- FranceTRANSLARNA 1000 mg, granulés pour suspension buvablePTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- PolandTranslarnaPTC Therapeutics International Limited
- BelgiumTranslarna 1000 mgPTC Therapeutics
- United KingdomTranslarna 1,000mg granules for oral suspension sachetsPTC Therapeutics Ltd
- IrelandTranslarnaPTC Therapeutics International Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/558c9c98-29f8-4d5e-a611-6ac12da07c4f GET /v1/drugs/558c9c98-29f8-4d5e-a611-6ac12da07c4f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2.8",
"form": "rakeet oraalisuspensiota varten",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "1000 mg",
"atc_label": "atalureeni",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/13/902/003",
"fimea_rel_id": "REL43071",
"authorised_at": "2014-07-31"
}See everything about ataluren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.